Clinical Trials with Pegylated Liposomal Doxorubicin in the Treatment of Ovarian Cancer

Among the pharmaceutical options available for treatment of ovarian cancer, increasing attention has been progressively focused on pegylated liposomal doxorubicin (PLD), whose unique formulation prolongs the persistence of the drug in the circulation and potentiates intratumor accumulation. Pegylate...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
Main Authors: Pisano, Carmela, Cecere, Sabrina Chiara, Di Napoli, Marilena, Cavaliere, Carla, Tambaro, Rosa, Facchini, Gaetano, Scaffa, Cono, Losito, Simona, Pizzolorusso, Antonio, Pignata, Sandro
Format: Artigo
Jezik:Inglês
Izdano: Hindawi Publishing Corporation 2013
Teme:
Review Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC3612436/
https://ncbi.nlm.nih.gov/pubmed/23577259
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2013/898146
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki